The Institute of Molecular and Translational Medicine, Czech Republic   Report issue

Academic/Hospital Phase 2 Phase 4
Founded: Czech Republic (2010)

Organization Overview

First Clinical Trial
2015
NCT02314871
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

Marian Hajduch, M.D., Ph.D. | The Institute of Molecular and Translational Medicine, Czech Republic

Active Ingredients

Drugs in Phase 4 Trials (2)

morphine (3 trials)

piritramide (3 trials)

Drugs in Phase 2 Trials (1)

disulfiram (antabuse) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Breast Neoplasms (Phase 2)

Colonic Neoplasms (Phase 4)

Colorectal Neoplasms (Phase 4)

Neoplasm, Residual (Phase 4)

Neoplastic Cells, Circulating (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 4
  • # of Trial APIs: 3